Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
about
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthmaCysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association StudiesRecent advances in the management of asthma using leukotriene modifiersRelease of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patientsG-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveA review on leukotrienes and their receptors with reference to asthmaMontelukast: data from clinical trials in the management of asthma.Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma.The genetic basis of atopic asthma.New perspectives for asthma treatment: anti-leukotriene drugs.Measurement of leukotrienes in humans.Antileukotriene therapy. Future directions.Anti-leukotrienes in asthma: yet to arrive.Leukotrienes, leukotriene receptor antagonists, and rhinitis.Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response.Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.Pharmacogenetics of asthma.The pharmacogenetics of asthma: a candidate gene approach.Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine.Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients.Plasminogen activator inhibitor-1 in the pathogenesis of asthma.An update of the leukotriene modulators for the treatment of asthma.Emerging anti-inflammatory agents for allergic rhinitis.New approaches to managing asthma: a US perspectiveEffect of leukotriene inhibitor on salicylate induced morphologic changes of isolated cochlear outer hair cells.Effects of Singulair (montelukast) treatment for capsular contracture.Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma.Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.New directions in asthma drug therapy.Medical and ventilatory management of status asthmaticus.Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity.Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis.Interleukin-2-induced increased airway responsiveness and lung Th2 cytokine expression occur after antigen challenge through the leukotriene pathway.Traditional Chinese medicine as an adjunctive therapy to oral montelukast for treating patients with chronic asthma.Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease.Pharmacogenetics of AsthmaShould Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?
P2860
Q24564777-3E79FF8C-7A7C-4B46-A8AB-C88B26944D88Q28067073-65D91603-F9B7-4704-8D0C-EB7E57E56A4DQ28166742-859BC002-4C49-4334-BD6A-640F1773F2CAQ28190812-AA040591-CA05-45C7-A588-0F719FDB218EQ28212087-1D029483-9901-48BD-AF33-DE4AC2FC77F1Q28294597-6FD79667-B35C-4DB8-903A-629BE34ACEDCQ31448541-EA46FBAD-7153-4E23-B0D1-A8644D7A7616Q33593217-A024FDD7-B170-4675-A6A0-EC65A948B297Q33717431-4F6C9A88-548B-49E0-8290-06A84A3862A4Q33729339-06D16B79-F6A7-4338-8D8C-2B9032EB99DCQ33836740-BD598422-9023-45D9-BBA2-C9D43ABABBF7Q33836782-2F68225F-FA32-4682-8FC9-765B1042E98AQ33930448-CB1FBC83-F3B0-4264-9265-F5266BF245F0Q33937511-2C60E050-63BF-4CDA-90CA-49334F1A91B3Q33969168-37C5B984-6B4E-4E07-AD2D-9616B9FEE16BQ34240729-1FD228B4-4215-473E-8FB2-6ED011A1222CQ34291204-C4CAC614-CE8B-489C-A44B-D37889FC98D1Q34534425-17B472B1-2CC2-462E-84E3-11F3FE121CF3Q34576923-7C7A9542-C408-4989-98D2-3ED6620728C0Q35532197-2822073E-643A-42A9-BA3C-C1B8C544F0D4Q35573060-B1EEA639-AEF1-4024-B75C-0B7E5D15D280Q35634264-9607C200-9039-44B4-9908-E74BF1C8EAE6Q35814442-E5E6502B-FA81-4447-8013-436962D068ADQ36302823-4BC6F655-061C-4BC6-BE9C-10FF93D92C7DQ36823534-9F2DC215-331E-40C5-A923-02029B1F7D8AQ36854303-8B9FFF66-303E-47C2-AD93-0122E32D71D3Q37769992-BFC918AD-E3AD-4935-A57C-E01D9EDEFE97Q38308690-844313BC-FDE9-4CDB-8BF0-D53231EE98A6Q40702893-65826A16-C2B9-4EC8-A171-4B685DA57E5CQ41713356-46C55635-1943-444C-8C00-5593DA86193AQ41737153-6B205166-1C03-464E-BEDA-F623DF39728EQ42756727-F82B0DC6-127F-4451-84F0-D5E00EC05115Q43700115-7E380559-10CE-4997-9B7F-F68D4A0E8950Q44014999-D49CA4BF-CAED-46F3-9AFA-DC5851E3446EQ47640302-A8ABCFA4-51A3-422C-9F11-A72DF9211CEDQ55067678-B53DD5B4-27B6-411F-ABAC-542CFD4DEF72Q57240710-564860BA-E35E-45C9-AEC0-DA07DB6B9FC1Q57240765-54E067C5-9254-434A-BA8A-A4795DA7244C
P2860
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@ast
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@en
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@nl
type
label
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@ast
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@en
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@nl
prefLabel
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@ast
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@en
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@nl
P1476
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.
@en
P2093
Bradding P
Sampson AP
P356
10.1016/S0091-6749(96)70220-8
P407
P577
1996-07-01T00:00:00Z